Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $28.0 million.

  • Neuronetics' Cash & Equivalents rose 3418.32% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 3418.32%. This contributed to the annual value of $18.5 million for FY2024, which is 6906.85% down from last year.
  • According to the latest figures from Q3 2025, Neuronetics' Cash & Equivalents is $28.0 million, which was up 3418.32% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Cash & Equivalents registered a high of $121.3 million during Q1 2021, and its lowest value of $11.0 million during Q2 2025.
  • For the 5-year period, Neuronetics' Cash & Equivalents averaged around $58.5 million, with its median value being $55.4 million (2023).
  • Per our database at Business Quant, Neuronetics' Cash & Equivalents surged by 11444.44% in 2021 and then plummeted by 7420.38% in 2025.
  • Quarter analysis of 5 years shows Neuronetics' Cash & Equivalents stood at $94.1 million in 2021, then fell by 25.28% to $70.3 million in 2022, then fell by 15.16% to $59.7 million in 2023, then plummeted by 69.07% to $18.5 million in 2024, then surged by 51.69% to $28.0 million in 2025.
  • Its Cash & Equivalents stands at $28.0 million for Q3 2025, versus $11.0 million for Q2 2025 and $20.2 million for Q1 2025.